February 2025 - Page 11 of 34

New Insights from the MARGOT/TBCRC052 Trial on HER2+ Breast Cancer Treatment

By Peng Longmei 2025.02.20

The MARGOT/TBCRC052 trial, presented at SABCS 2024, explored the efficacy of margetuximab + paclitaxel + pertuzumab (TMP) versus the standard trastuzumab + paclitaxel + pertuzumab (THP) in HER2+ stage II-III…

Throwback to #SABCS24: Key Insights from the ZEST Trial

By Mourabit Halima 2025.02.20

Prof. Nicholas Turner and colleagues presented findings from ZEST, the first Phase 3 trial evaluating MRD-guided therapy in breast cancer using circulating tumor DNA (ctDNA) surveillance.

New Insights on Tamoxifen Use After Breast Conservation Surgery for DCIS!

By Mourabit Halima 2025.02.20

At SABCS, Jean Wright presented a new analysis from the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 trials, providing critical insights into the role of tamoxifen for patients with "good risk"…

Advancing Precision Medicine in Prostate Cancer: Expert Insights from Professor Qiu Xuefeng & Dr. Darren Poon

By Mourabit Halima 2025.02.20

How are PARP inhibitors, ARPIs, and radioligand therapy reshaping the treatment landscape for mCRPC? In this exclusive conversation, Professor Qiu Xuefeng and Dr. Darren Poon dive into the latest advancements in precision oncology, discussing key challenges, emerging therapies, and the impact of HRR and BRCA testing on treatment decisions.

Throwback to #SABCS24: Final Survival Results from the ADAPT HR+/HER2- Trial

By Mourabit Halima 2025.02.20

Prof. Sherko Kuemmel and the WSG Study Group presented key findings from the ADAPT HR+/HER2- chemotherapy trial, refining treatment strategies for high-risk HR+/HER2- early breast cancer.

WCLC 2024 | Selected Oral Presentations: Novel Immunotherapy Strategies and Combination Therapies

By Mourabit Halima 2025.02.20

The 2024 World Conference on Lung Cancer is happening in San Diego from September 7th to 10th! The WCLC website has already released some groundbreaking abstracts. Here are the key…

WCLC 2024 | Selected Oral Presentations: Treatment of Pleural Mesothelioma, Thymic Carcinoma, and Undifferentiated Thoracic Tumors

By Peng Longmei 2025.02.20

The 2024 World Conference on Lung Cancer is happening in San Diego from September 7th to 10th! The WCLC website has already released important abstracts. Below are some key research…

Month: February 2025

New Insights from the MARGOT/TBCRC052 Trial on HER2+ Breast Cancer Treatment

Throwback to #SABCS24: Key Insights from the ZEST Trial

New Insights on Tamoxifen Use After Breast Conservation Surgery for DCIS!

Advancing Precision Medicine in Prostate Cancer: Expert Insights from Professor Qiu Xuefeng & Dr. Darren Poon

Throwback to #SABCS24: Final Survival Results from the ADAPT HR+/HER2- Trial

WCLC 2024 | Selected Oral Presentations: Novel Immunotherapy Strategies and Combination Therapies

WCLC 2024 | Selected Oral Presentations: Treatment of Pleural Mesothelioma, Thymic Carcinoma, and Undifferentiated Thoracic Tumors

WCLC 2024 | Selected Oral Presentations: Multimodal Treatment of Stage III Lung Cancer

WCLC 2024 | Selected Oral Presentations: Optimizing the Timing of Supportive Care

New Insights on Extended Anticoagulation for Venous Thromboembolism